Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05936047Completed
Open-label, single-arm trial in Degenerative spine disease, sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Brantigan classification at 12 months. Started Nov 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05936047.